161 related articles for article (PubMed ID: 34375669)
21. Combination therapy for perianal squamous cell carcinoma in situ with imiquimod and photodynamic therapy.
Bontumasi NM; Sheinbein D; Hurst EA
Cutis; 2014 Nov; 94(5):252-4. PubMed ID: 25474454
[TBL] [Abstract][Full Text] [Related]
22. Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study.
Hsu SH; Gan SD; Nguyen BT; Konnikov N; Liang CA
Dermatol Surg; 2016 Sep; 42(9):1050-3. PubMed ID: 27359199
[TBL] [Abstract][Full Text] [Related]
23. Combination Topical Chemotherapy for the Treatment of an Invasive Cutaneous Squamous Cell Carcinoma.
Fayne R; Nanda S; Nichols A; Shen J
J Drugs Dermatol; 2020 Feb; 19(2):202-204. PubMed ID: 32155018
[TBL] [Abstract][Full Text] [Related]
24. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Bahner JD; Bordeaux JS
Clin Dermatol; 2013; 31(6):792-8. PubMed ID: 24160289
[TBL] [Abstract][Full Text] [Related]
25. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and treatment of Basal cell and squamous cell carcinoma.
Firnhaber JM
Am Fam Physician; 2012 Jul; 86(2):161-8. PubMed ID: 22962928
[TBL] [Abstract][Full Text] [Related]
27. Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
Terushkin V; Braga JC; Dusza SW; Scope A; Busam K; Marghoob AA; Gill M; Halpern AC
Dermatol Surg; 2010 Oct; 36(10):1514-20. PubMed ID: 20698872
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment.
Arlette JP; Trotter MJ
Australas J Dermatol; 2004 Feb; 45(1):1-9; quiz 10. PubMed ID: 14961900
[TBL] [Abstract][Full Text] [Related]
29. Intralesional 5-Fluorouracil in the Treatment of Lower Leg Squamous Cell Carcinoma.
Mackey M; Shahsavari A; Mackey VT
J Drugs Dermatol; 2018 Nov; 17(11):1241-1243. PubMed ID: 30500149
[TBL] [Abstract][Full Text] [Related]
30. Rapid Evolution of a Squamous Cell Carcinoma In Situ to Locally Invasive With Perineural Involvement.
Juhasz M; Cohen JL
J Drugs Dermatol; 2020 Nov; 19(11):1110-1111. PubMed ID: 33196738
[TBL] [Abstract][Full Text] [Related]
31. Statins are associated with increased risk of squamous cell carcinoma of the skin: a whole-population study from Iceland.
Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Feng H; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
Arch Dermatol Res; 2022 Oct; 314(8):805-808. PubMed ID: 33772628
[TBL] [Abstract][Full Text] [Related]
32. Expression of G1/S-cyclins and cyclin-dependent kinase inhibitors in actinic keratosis and squamous cell carcinoma.
Brasanac D; Stojkovic-Filipovic J; Bosic M; Tomanovic N; Manojlovic-Gacic E
J Cutan Pathol; 2016 Mar; 43(3):200-10. PubMed ID: 26349899
[TBL] [Abstract][Full Text] [Related]
33. Electrodesiccation and Curettage for Squamous Cell Carcinoma in Situ: The Effect of Anatomic Location on Local Recurrence.
Veverka KK; Stratman EJ
Dermatol Surg; 2023 Sep; 49(9):821-824. PubMed ID: 37279310
[TBL] [Abstract][Full Text] [Related]
34. Nonsurgical Treatments for Nonmelanoma Skin Cancer.
Collins A; Savas J; Doerfler L
Dermatol Clin; 2019 Oct; 37(4):435-441. PubMed ID: 31466584
[TBL] [Abstract][Full Text] [Related]
35. Treatment Patterns, Outcomes, and Patient Satisfaction of Primary Epidermally Limited Nonmelanoma Skin Cancer.
Drew BA; Karia PS; Mora AN; Liang CA; Schmults CD
Dermatol Surg; 2017 Dec; 43(12):1423-1430. PubMed ID: 28661992
[TBL] [Abstract][Full Text] [Related]
36. Nonmelanoma skin cancer.
Nguyen TH; Ho DQ
Curr Treat Options Oncol; 2002 Jun; 3(3):193-203. PubMed ID: 12057065
[TBL] [Abstract][Full Text] [Related]
37. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends.
Kallini JR; Hamed N; Khachemoune A
Int J Dermatol; 2015 Feb; 54(2):130-40. PubMed ID: 25428226
[TBL] [Abstract][Full Text] [Related]
38. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy.
Smith KJ; Germain M; Skelton H
Dermatol Surg; 2001 Jun; 27(6):561-4. PubMed ID: 11442593
[TBL] [Abstract][Full Text] [Related]
39. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
J Am Acad Dermatol; 2021 Mar; 84(3):669-675. PubMed ID: 32791082
[TBL] [Abstract][Full Text] [Related]
40. Expression of gelatinases (MMP-2, MMP-9) and gelatinase activator (MMP-14) in actinic keratosis and in in situ and invasive squamous cell carcinoma.
Hernández-Pérez M; El-hajahmad M; Massaro J; Mahalingam M
Am J Dermatopathol; 2012 Oct; 34(7):723-8. PubMed ID: 22534634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
